Advanced Biomed Inc. financial data

Symbol
ADVB on Nasdaq
Location
Reno, NV
Latest financial report
10-Q - Q4 2025 - 13 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 203% %
Debt-to-equity 95% %
Return On Equity 87% %
Return On Assets 45% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 21,640,000 shares
Common Stock, Shares, Outstanding 21,640,000 shares 8.2%
Common Stock, Value, Issued $21,640 USD 8.2%
Weighted Average Number of Shares Outstanding, Basic 21,640,000 shares 8.2%
Weighted Average Number of Shares Outstanding, Diluted 21,640,000 shares 8.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $937,994 USD -12%
General and Administrative Expense $2,203,507 USD 211%
Nonoperating Income (Expense) $7,342,883 USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,201,382 USD
Net Income (Loss) Attributable to Parent $4,385,535 USD
Earnings Per Share, Basic 0.19 USD/shares
Earnings Per Share, Diluted 0.19 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $10,731,565 USD 242%
Property, Plant and Equipment, Net $97,100 USD -76%
Operating Lease, Right-of-Use Asset $21,091 USD -91%
Other Assets, Noncurrent $956 USD
Assets $10,850,712 USD 141%
Accounts Payable, Current $369,293 USD -40%
Accrued Liabilities, Current $224,038 USD
Liabilities, Current $1,253,574 USD -67%
Operating Lease, Liability, Noncurrent $1,431 USD -97%
Liabilities $1,369,070 USD -65%
Accumulated Other Comprehensive Income (Loss), Net of Tax $874,748 USD -30%
Retained Earnings (Accumulated Deficit) $12,762,024 USD 26%
Stockholders' Equity Attributable to Parent $9,481,642 USD 1432%
Liabilities and Equity $10,850,712 USD 141%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 21,640,000 shares 8.2%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,604,666 USD -1.6%
Deferred Tax Assets, Valuation Allowance $1,695,405 USD -18%
Operating Lease, Liability $21,092 USD -93%
Depreciation $198,013 USD -34%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $4,007,681 USD
Lessee, Operating Lease, Liability, to be Paid $21,326 USD -93%
Property, Plant and Equipment, Gross $1,070,530 USD -39%
Operating Lease, Liability, Current $19,661 USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,515 USD -94%
Operating Lease, Weighted Average Discount Rate, Percent 0.0341 pure -7.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $234 USD -96%
Deferred Tax Assets, Operating Loss Carryforwards $1,695,405 USD -18%